Cardiac Biomarkers Market Size, Share & Trends Analysis Report By Type (Troponin, CK-MB, Myoglobin, BNP and NT-proBNP, Others), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Type
                        1.2.2. Application
                        1.2.3. End Use
                        1.2.4. Regional scope
                        1.2.5. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Type
                        2.2.2. Application
                        2.2.3. End Use
                        2.2.4. Regional outlook
                    2.3. Competitive Insights
Chapter 3. Cardiac Biomarkers Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market outlook
                        3.1.2. Related/ancillary Market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                        3.2.2. Market restraint analysis
                    3.3. Cardiac Biomarkers Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
                    3.4. Cardiac Biomarkers Market : Pipeline Analysis
Chapter 4. Cardiac Biomarkers Market : Type Estimates & Trend Analysis
                    4.1. Type Segment Dashboard
                    4.2. Cardiac Biomarkers Market: Type Movement Analysis
                    4.3. Global Cardiac Biomarkers Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
                    4.4. Troponin
                        4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.5. CK-MB
                        4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.6. Myoglobin
                        4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.7. Irreversible Electroporation Ablation
                        4.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.8. BNP AND NT-PROBNP
                        4.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.9. Others
                        4.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Cardiac Biomarkers Market : Application Estimates & Trend Analysis
                    5.1. Application Segment Dashboard
                    5.2. Cardiac Biomarkers Market: Application Movement Analysis
                    5.3. Global Cardiac Biomarkers Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
                    5.4. Acute Coronary Syndrome
                        5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                    5.5. Myocardial Infarction
                        5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                    5.6. Congestive Heart Failure
                        5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                    5.7. Others
                        5.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Cardiac Biomarkers Market: End Use Estimates & Trend Analysis
                    6.1. End Use Segment Dashboard
                    6.2. Cardiac Biomarkers Market: End Use Movement Analysis
                    6.3. Global Cardiac Biomarkers Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
                    6.4. Laboratory Testing
                        6.4.1. Market estimates and forecasts, 2018 to 2030 (USD million)
                    6.5. Point of Care Testing
                        6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Cardiac Biomarkers Market : Regional Estimates & Trend Analysis
                    7.1. Regional Market Dashboard
                    7.2. Regional Market Share Analysis, 2024 & 2030
                    7.3. Continuous bioprocessing Market by Region: Key Takeaways
                    7.4. North America
                        7.4.1. U.S.
                            7.4.1.1. Key country dynamics
                            7.4.1.2. Regulatory framework/ reimbursement structure
                            7.4.1.3. Competitive scenario
                            7.4.1.4. U.S. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.4.2. Canada
                            7.4.2.1. Key country dynamics
                            7.4.2.2. Regulatory framework/ reimbursement structure
                            7.4.2.3. Competitive scenario
                            7.4.2.4. Canada Market estimates and forecasts 2018 to 2030 (USD Million)
                        7.4.3. Mexico
                            7.4.3.1. Key country dynamics
                            7.4.3.2. Regulatory framework/ reimbursement structure
                            7.4.3.3. Competitive scenario
                            7.4.3.4. Mexico Market estimates and forecasts, 2018 to 2030 (USD Million)
                    7.5. Europe
                        7.5.1. UK
                            7.5.1.1. Key country dynamics
                            7.5.1.2. Regulatory framework/ reimbursement structure
                            7.5.1.3. Competitive scenario
                            7.5.1.4. UK Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.5.2. Germany
                            7.5.2.1. Key country dynamics
                            7.5.2.2. Regulatory framework/ reimbursement structure
                            7.5.2.3. Competitive scenario
                            7.5.2.4. Germany Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.5.3. France
                            7.5.3.1. Key country dynamics
                            7.5.3.2. Regulatory framework/ reimbursement structure
                            7.5.3.3. Competitive scenario
                            7.5.3.4. France Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.5.4. Italy
                            7.5.4.1. Key country dynamics
                            7.5.4.2. Regulatory framework/ reimbursement structure
                            7.5.4.3. Competitive scenario
                            7.5.4.4. Italy Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.5.5. Spain
                            7.5.5.1. Key country dynamics
                            7.5.5.2. Regulatory framework/ reimbursement structure
                            7.5.5.3. Competitive scenario
                            7.5.5.4. Spain Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.5.6. Norway
                            7.5.6.1. Key country dynamics
                            7.5.6.2. Regulatory framework/ reimbursement structure
                            7.5.6.3. Competitive scenario
                            7.5.6.4. Norway Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.5.7. Sweden
                            7.5.7.1. Key country dynamics
                            7.5.7.2. Regulatory framework/ reimbursement structure
                            7.5.7.3. Competitive scenario
                            7.5.7.4. Sweden Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.5.8. Denmark
                            7.5.8.1. Key country dynamics
                            7.5.8.2. Regulatory framework/ reimbursement structure
                            7.5.8.3. Competitive scenario
                            7.5.8.4. Denmark Market estimates and forecasts, 2018 to 2030 (USD Million)
                    7.6. Asia Pacific
                        7.6.1. Japan
                            7.6.1.1. Key country dynamics
                            7.6.1.2. Regulatory framework/ reimbursement structure
                            7.6.1.3. Competitive scenario
                            7.6.1.4. Japan Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.6.2. China
                            7.6.2.1. Key country dynamics
                            7.6.2.2. Regulatory framework/ reimbursement structure
                            7.6.2.3. Competitive scenario
                            7.6.2.4. China Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.6.3. India
                            7.6.3.1. Key country dynamics
                            7.6.3.2. Regulatory framework/ reimbursement structure
                            7.6.3.3. Competitive scenario
                            7.6.3.4. India Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.6.4. Australia
                            7.6.4.1. Key country dynamics
                            7.6.4.2. Regulatory framework/ reimbursement structure
                            7.6.4.3. Competitive scenario
                            7.6.4.4. Australia Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.6.5. South Korea
                            7.6.5.1. Key country dynamics
                            7.6.5.2. Regulatory framework/ reimbursement structure
                            7.6.5.3. Competitive scenario
                            7.6.5.4. South Korea Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.6.6. Thailand
                            7.6.6.1. Key country dynamics
                            7.6.6.2. Regulatory framework/ reimbursement structure
                            7.6.6.3. Competitive scenario
                            7.6.6.4. Thailand Market estimates and forecasts, 2018 to 2030 (USD Million)
                    7.7. Latin America
                        7.7.1. Brazil
                            7.7.1.1. Key country dynamics
                            7.7.1.2. Regulatory framework/ reimbursement structure
                            7.7.1.3. Competitive scenario
                            7.7.1.4. Brazil Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.7.2. Argentina
                            7.7.2.1. Key country dynamics
                            7.7.2.2. Regulatory framework/ reimbursement structure
                            7.7.2.3. Competitive scenario
                            7.7.2.4. Argentina Market estimates and forecasts, 2018 to 2030 (USD Million)
                    7.8. MEA
                        7.8.1. South Africa
                            7.8.1.1. Key country dynamics
                            7.8.1.2. Regulatory framework/ reimbursement structure
                            7.8.1.3. Competitive scenario
                            7.8.1.4. South Africa Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.8.2. Saudi Arabia
                            7.8.2.1. Key country dynamics
                            7.8.2.2. Regulatory framework/ reimbursement structure
                            7.8.2.3. Competitive scenario
                            7.8.2.4. Saudi Arabia Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.8.3. UAE
                            7.8.3.1. Key country dynamics
                            7.8.3.2. Regulatory framework/ reimbursement structure
                            7.8.3.3. Competitive scenario
                            7.8.3.4. UAE Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.8.4. Kuwait
                            7.8.4.1. Key country dynamics
                            7.8.4.2. Regulatory framework/ reimbursement structure
                            7.8.4.3. Competitive scenario
                            7.8.4.4. Kuwait Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Recent Developments & Impact Analysis, By Key Market Participants
                    8.2. Company/Competition Categorization
                    8.3. Vendor Landscape
                        8.3.1. Key company heat map analysis, 2024
                    8.4. Company Profiles
                        8.4.1. Abbott
                            8.4.1.1. Company overview
                            8.4.1.2. Financial performance
                            8.4.1.3. Product benchmarking
                            8.4.1.4. Strategic initiatives
                        8.4.2. Quidel Corporatio
                            8.4.2.1. Company overview
                            8.4.2.2. Financial performance
                            8.4.2.3. Product benchmarking
                            8.4.2.4. Strategic initiatives
                        8.4.3. Siemens Healthcare Gmbh
                            8.4.3.1. Company overview
                            8.4.3.2. Financial performance
                            8.4.3.3. Product benchmarking
                            8.4.3.4. Strategic initiatives
                        8.4.4. F. Hoffmann-La Roche Ltd.
                            8.4.4.1. Company overview
                            8.4.4.2. Financial performance
                            8.4.4.3. Product benchmarking
                            8.4.4.4. Strategic initiatives
                        8.4.5. Danaher
                            8.4.5.1. Company overview
                            8.4.5.2. Financial performance
                            8.4.5.3. Product benchmarking
                            8.4.5.4. Strategic initiatives
                        8.4.6. BIOMÉRIEUX
                            8.4.6.1. Company overview
                            8.4.6.2. Financial performance
                            8.4.6.3. Product benchmarking
                            8.4.6.4. Strategic initiatives
                        8.4.7. Bio-Rad Laboratories, Inc.
                            8.4.7.1. Company overview
                            8.4.7.2. Financial performance
                            8.4.7.3. Product benchmarking
                            8.4.7.4. Strategic initiatives
                        8.4.8. Randox Laboratories Ltd.
                            8.4.8.1. Company overview
                            8.4.8.2. Financial performance
                            8.4.8.3. Product benchmarking
                            8.4.8.4. Strategic initiatives
                        8.4.9. Creative Diagnostics
                            8.4.9.1. Company overview
                            8.4.9.2. Financial performance
                            8.4.9.3. Product benchmarking
                            8.4.9.4. Strategic initiatives
                        8.4.10. Life Diagnostics
                            8.4.10.1. Company overview
                            8.4.10.2. Financial performance
                            8.4.10.3. Product benchmarking
                            8.4.10.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 North America cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 3 North America cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 4 North America cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 5 North America cardiac biomarkers market, by region, 2018 - 2030 (USD Million)
Table 6 U.S cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 7 U.S cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 8 U.S cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 9 Canada cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 10 Canada cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 11 Canada cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 12 Europe cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 13 Europe cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 14 Europe cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 15 Europe cardiac biomarkers market, by region, 2018 - 2030 (USD Million)
Table 16 Germany cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 17 Germany cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 18 Germany cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 19 UK cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 20 UK cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 21 UK cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 22 France cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 23 France cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 24 France cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 25 Italy cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 26 Italy cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 27 Italy cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 28 Spain cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 29 Spain cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 30 Spain cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 31 Denmark cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 32 Denmark cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 33 Denmark cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 34 Sweden cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 35 Sweden cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 36 Sweden cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 37 Norway cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 38 Norway cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 39 Norway cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 40 Asia Pacific cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 41 Asia Pacific cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 42 Asia Pacific cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 43 Asia Pacific cardiac biomarkers market, by region, 2018 - 2030 (USD Million)
Table 44 Japan cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 45 Japan cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 46 Japan cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 47 China cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 48 China cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 49 China cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 50 India cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 51 India cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 52 India cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 53 Australia cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 54 Australia cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 55 Australia cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 56 Thailand cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 57 Thailand cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 58 Thailand cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 59 South Korea cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 60 South Korea cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 61 South Korea cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 62 Latin America cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 63 Latin America cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 64 Latin America cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 65 Latin America cardiac biomarkers market, by region, 2018 - 2030 (USD Million)
Table 66 Brazil cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 67 Brazil cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 68 Brazil cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 69 Mexico cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 70 Mexico cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 71 Mexico cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 72 Argentina cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 73 Argentina cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 74 Argentina cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa cardiac biomarkers market, by region, 2018 - 2030 (USD Million)
Table 79 South Africa cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 80 South Africa cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 81 South Africa cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 85 UAE cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 86 UAE cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 87 UAE cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
Table 88 Kuwait cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
Table 89 Kuwait cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
Table 90 Kuwait cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Cardiac biomarkers: Market outlook
Fig. 8 Cardiac biomarkers: Competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Cardiac biomarkers market driver impact
Fig. 13 Cardiac biomarkers market restraint impact
Fig. 14 Cardiac biomarkers market strategic initiatives analysis
Fig. 15 Cardiac biomarkers market: Type movement analysis
Fig. 16 Cardiac biomarkers market: Type outlook and key takeaways
Fig. 17 Troponin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 CK-MB market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Myoglobin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 BNP and NT-proBNP market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Cardiac biomarkers market: Application movement analysis
Fig. 23 Cardiac biomarkers market: Application outlook and key takeaways
Fig. 24 Acute coronary syndrome market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Myocardial infarction market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Congestive heart failure market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Other applications market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Cardiac biomarkers market: End use movement analysis
Fig. 29 Cardiac biomarkers market: End use outlook and key takeaways
Fig. 30 Laboratory testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Point of care testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Pain management market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Cancer therapy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Vaccine delivery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Other end use market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Global cardiac biomarkers market: Regional movement analysis
Fig. 37 Global cardiac biomarkers market: Regional outlook and key takeaways
Fig. 38 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 U.S market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)